Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Pochapin MD

Mark B. Pochapin MD

Director, Division of Gastroenterology and Hepatology, and Vice-Chair, Clinical Affairs, Department of Medicine; Sholtz-Leeds Professor of Gastroenterology, NYU Langone Health, New York, New York

Mark B. Pochapin, MD, FACG, FASGE, FACP, is the Sholtz-Leeds Professor of Gastroenterology, Director of the Division of Gastroenterology and Hepatology, and Vice Chair of Clinical Affairs in the Department of Medicine at NYU Grossman School of Medicine / NYU Langone Health. In his clinical and research efforts, Dr. Pochapin is dedicated to the prevention, early detection, and treatment of gastrointestinal cancers and to quality in endoscopy. Over the past 25 years, Dr. Pochapin has been a leader in the national effort to increase colorectal cancer screening and promote quality in colonoscopy. He has held leadership positions with the National Colorectal Cancer Roundtable (NCCRT) and New York Citywide Coalition for Colon Cancer Control (C5), and was on the Board of Directors of the GI Quality Improvement Consortium (GIQuIC). Dr. Pochapin currently hosts two alternating weekly national radio broadcasts called "Chiefs Rounds" and “Medicine Grand Rounds” on SiriusXM Doctor Radio, connecting the listening public with leading medical experts and valuable health information.

Dr. Pochapin is the immediate past president of the American College of Gastroenterology (ACG) and remains a member of the ACG Board of Trustees. For his leadership during the COVID pandemic, in 2020 he became the first recipeint of a new award from the ACG named the Beacon Award for “outstanding leadership in extraordinary times."


Dr. Pochapin is a clinical advisor and has stock options for AcuamarkDx, a blood test for colon cancer. He holds intellectual rights for a small endoscopic ruler called the Napoleon (named because it is a “small ruler”), made by Micro-Tech.